ForeBatten Foundation launches national campaign to fund Batten disease research This campaign turns a birthday ...
NICE has consistently questioned the long-term benefits of Brineura, also known as Cerliponase alfa. In 2019 they negotiated ...
THX Pharma is set to receive total payments up to $206.1m.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results